Compare the pharmacology of Aspirin, Diclofenac, and Paracetamol.
Aspirin (Acetylsalicylic acid):
- Mechanism of Action: Aspirin inhibits both COX-1 and COX-2 enzymes, which are responsible for the production of prostaglandins (PGF2alpha), substances that mediate pain and inflammation. It also inhibits the conversion of arachidonic acid to thromboxane A2, a potent inducer of platelet aggregation.
Low-dose aspirin use irreversibly blocks the formation of thromboxane A2 in mature platelets by inhibiting the COX-1 enzyme, producing an inhibitory effect on platelet aggregation during the lifetime of the affected platelet (8–9 days) and acts as a blood thinner.
- Indications: Aspirin is used to treat pain, fever, and inflammation associated with various conditions. It is also used as antiplatelet agent sometimes in low doses.
- Pharmacokinetics: Aspirin is rapidly and completely absorbed after oral administration. It is widely distributed in the body in protein-bound form.
- Prevention of Toxicity: Sodium bicarbonate and gastric lavage
Diclofenac:
- Mechanism of Action: Diclofenac, like other NSAIDs, inhibits COX-1 and COX-2 enzymes (but COX - 2 preferably), which are involved in prostaglandin synthesis. This results in analgesic, anti-inflammatory, and antipyretic properties. (As COX -2 dependent pathway is majorly and Principally involved in inflammatory response is is better selective Analgesic and anti-inflammatory agent)
- Indications: Diclofenac is used to treat the signs and symptoms of osteoarthritis and rheumatoid arthritis.
- Pharmacokinetics: Diclofenac is well-absorbed from the gastrointestinal tract and readily inactivated in the liver by conjugation to its glucuronide and sulfate.
- Treatment for Toxicity: Gastric lavage, charcoal
Paracetamol (Acetaminophen):
- Mechanism of Action: Paracetamol is thought to act primarily in the CNS, increasing the pain threshold by inhibiting both isoforms of cyclooxygenase, COX-1, COX-2, and COX-3 enzymes involved in prostaglandin synthesis.
- Indications: Paracetamol is used for the relief of mild to moderate pain, and for relieving fever.
- Pharmacokinetics: Paracetamol is well-absorbed from the gastrointestinal tract. Its systemic bioavailability is dose-dependent and ranges from 70 to 90%.
- Toxicity Treatment: N acetylcysteine
|
Aspirin |
Diclofenac |
Paracetamol |
Class |
Non-selective COX inhibitor NSAID |
Preferential COX – 2 Inhibitor NSAID |
Analgesic, Antipyretic with poor
Anti-inflammatory Action (Non-NSAID) |
Mode of Action |
Blocks both COX-1 and COX-2
irreversibly and inhibits the production of -
Inflammatory Mediators (PGE2, PGF,
PGI2) -
Thromboxane A2 |
Inhibits COX- 2 preferentially.
And inhibits the production of Inflammatory Prostaglandins MAJORLY. |
Inhibits Both COX-1 and COX-2 and
inhibits PG synthesis in BRAIN.
Modulation in Endocannabinoid
System |
Indication |
Analgesic, Anti-inflammatory, Blood
Thinner |
Anti-inflammatory, Analgesic (STRONG) |
Analgesic, Anti-pyretic,
Anti-inflammatory (MILD) |
Onset of Action
|
30 – 60 min |
15 – 60 min |
30 – 60 min |
Dose in adult
|
325 – 650 mg/4-6hrs |
50 – 100 mg/8 – 12hrs |
325 – 650 mg/4-6hrs |
MAX daily dose
|
4000 mg |
150 mg |
4000 mg |
Toxicity Treatment |
Sodium bicarbonate/ Gastric
lavage |
Activated Charcoal / gastric
lavage |
N-acetylcysteine |
Contraindications |
Gastric Ulcer, Asthma, Major surgery
|
Hepatic Disorder, Renal Disorder |
Hepatic Disorder |
Metabolism (In liver) |
ENZYME: COX – 1 METABOLITE: Salicylic Acid |
ENZYME:
CYP2C8, CYP2C9 METABOLITE: Glucuronide, Sulphate conjugates. |
ENZYME:
CYP2E1, CYP3A4 METABOLITE: Glucuronide,
Sulphate conjugates. |
Interactions |
Risk
of Bleeding with Anticoagulants and Thrombolytics. |
Risk of Bleeding with Anticoagulants and
Thrombolytics. |
May
Cause Hepatotoxicity with interaction to
other drugs. |
Comments
Post a Comment